In an age characterized by what some have termed an “epidemic of anxiety,” global societies are grappling with rising rates of generalized anxiety disorder, social anxiety, panic disorders, and related conditions. Concurrently, the consumption of intoxicants—ranging from legally sanctioned alcohol and cannabis to illicit substances—remains a prevalent, often culturally embedded, method of self-regulation and temporary relief. This presents a profound paradox: substances frequently used to alleviate distress in the short-term may, in fact, be significant contributors to its long-term perpetuation and exacerbation. This guidee posits that the philosophical and legal prohibition of intoxicants, while controversial, can be constructively examined through the lens of long-term anxiety prevention. By synthesizing evidence from neurobiology, psychology, and sociology, we will argue that systemic restrictions on intoxicant use align with protective public health principles aimed at fostering resilient mental well-being at both the individual and collective levels. This is not a simplistic endorsement of all prohibitive policies, but a detailed exploration of the mechanisms through which intoxicant avoidance serves as a primary preventive strategy against chronic anxiety pathology.
The Neurobiological Nexus – How Intoxicants Hijack Stress and Reward Pathways
To understand the link between intoxicants and anxiety, one must first appreciate the brain’s intricate stress and reward systems. The hypothalamic-pituitary-adrenal (HPA) axis is the body’s central stress response system. Under threat, it triggers the release of cortisol, a hormone that mobilizes energy and heightens alertness. In healthy individuals, this system is self-regulating. Chronic stress, however, can lead to HPA axis dysregulation, resulting in either blunted or excessively reactive cortisol responses—both states are correlated with anxiety disorders.
Most intoxicants directly or indirectly manipulate this system. Alcohol, for instance, is a central nervous system depressant that initially suppresses the HPA axis, producing temporary relaxation. Research by (Spanagel, Noori & Heilig, 2014) demonstrates that acute alcohol consumption inhibits corticotropin-releasing factor (CRF) in the amygdala. However, with chronic use, the brain adapts through neuroplastic changes. The system becomes sensitized, leading to a hyperactive HPA axis during withdrawal. This results in a state of heightened baseline anxiety, requiring more alcohol to quell—a core feature of alcohol use disorder and a direct pathway to alcohol-induced anxiety states.
Similarly, stimulants like cocaine and methamphetamine produce acute euphoria by flooding the synapse with dopamine, hijacking the mesolimbic reward pathway. The crash that follows is marked by a profound dopamine deficit and elevated stress hormones, creating a potent mix of dysphoria and agitation. The work of (Koob & Volkow, 2016) on the “dark side of addiction” outlines how repeated drug use leads to a shift from pleasure-seeking to relief-seeking from this negative emotional state, with anxiety being a primary driver. Even cannabis, often touted for its anxiolytic properties, has a complex, dose-dependent relationship with anxiety. While low doses of tetrahydrocannabinol (THC) may reduce anxiety, higher doses can precipitate anxiety and paranoia. Critically, longitudinal studies highlighted by (Gobbi et al., 2019) indicate that early and frequent cannabis use, particularly of high-potency varieties, is associated with an increased risk of developing anxiety disorders later in life, likely through disruption of endogenous cannabinoid signaling crucial for emotional regulation.
The neurobiological conclusion is stark: intoxicants pharmacologically mimic or force the very neurochemical states that characterize anxiety disorders. They create artificial cycles of relief and rebound, ultimately teaching the brain to be anxious. A policy of prohibition, from this perspective, is a policy of preventing this profound neurological hijacking.
The Psychological Trap: Avoidance Coping and the Erosion of Mastery
Psychological models of anxiety, particularly Cognitive Behavioral Therapy (CBT), emphasize the role of maladaptive coping strategies in maintaining disorders. The core pathology of anxiety often involves avoidance—avoidance of feared situations, internal sensations, or thoughts. Intoxicant use represents a powerful form of chemical avoidance. By using a substance to mute anxious feelings, the individual never learns that the anxiety itself is tolerable and can be managed through healthier means. This reinforces the perceived danger of the anxious state and ensures its return with greater force.
This process prevents the development of psychological resilience, or “distress tolerance.” When anxiety is consistently pharmacologically silenced, the individual’s repertoire of coping skills atrophies. They do not practice mindfulness, cognitive restructuring, problem-solving, or exposure. Research by (Kushner et al., 2000) established a robust bidirectional link between anxiety disorders and alcohol use disorders, where each condition worsens the other through precisely this avoidance mechanism. The substance use becomes a “safety behavior” that perpetuates the anxiety cycle.
Furthermore, intoxicants impair the executive functions of the prefrontal cortex—the seat of impulse control, future planning, and emotional regulation. Anxiety already taxes these systems; intoxication further degrades them. This creates a vicious cycle: anxiety leads to drinking to cope, drinking impairs the cognitive faculties needed to manage anxiety, leading to worse anxiety, prompting more drinking. A prohibitive framework interrupts this cycle at its origin. It forces, or at least strongly encourages, a societal engagement with anxiety through means that build mastery—therapy, social support, exercise, meditation—rather than through means that guarantee dependence and deterioration.
The Sociocultural Fabric: Normalization, Access, and Collective Well-being
Anxiety does not exist in a vacuum; it is shaped by cultural norms and environmental access. The legal and cultural status of an intoxicant profoundly influences its use patterns and related harm. The normalization of alcohol, for example, as a requisite for social bonding, celebration, and stress relief, creates a powerful cultural script that equates coping with consumption. This normalization increases both access and perceived acceptability, particularly for adolescents and young adults whose brains are most vulnerable to long-term perturbation.
Prohibition, or strict regulation, functions as a counter-cultural message. It communicates a societal judgment that the risks of a substance outweigh its benefits for the collective good. The “forbidden fruit” effect is often cited as a critique, but public health history provides nuanced lessons. The work of (Hall & Lynskey, 2020) on cannabis legalization suggests that while legalization for adult use may not lead to a dramatic spike in use, it invariably increases availability, potency, and social acceptance, potentially shifting population-level risk. Similarly, studies on alcohol control policies, such as those summarized by (Babor et al., 2010), consistently show that measures reducing availability and increasing price (forms of prohibition for certain demographics and contexts) are effective in reducing per-capita consumption and associated harms, including mental health burdens.
From a social determinant of health perspective, anxiety is often fueled by inequality, insecurity, and social fragmentation. Widespread intoxication can exacerbate these root causes. It is associated with increased crime, family dysfunction, economic productivity loss, and healthcare burdens—all of which are societal stressors that elevate background levels of insecurity and anxiety for the entire community. A policy orientation that restricts intoxicants can thus be seen as an attempt to foster a more stable, predictable, and coherent social environment, one inherently less conducive to the proliferation of anxiety disorders.
Criticisms, Nuances, and the Imperative of Harm Reduction
A rigorous examination demands engagement with the valid criticisms of prohibition. Historically, blanket prohibitions (e.g., the U.S. alcohol Prohibition) have led to unintended consequences: organized crime, the proliferation of unsafe products, and the disproportionate criminalization of marginalized groups. Furthermore, a purely prohibitive approach can stigmatize substance users, driving problematic use underground and creating barriers to seeking help. It may also ignore the role of safe, controlled use for some individuals.
This analysis does not advocate for a return to simplistic, punitive prohibition. Rather, it argues that the principle of prohibiting non-medical intoxicant use is sound when viewed through the singular lens of long-term anxiety prevention. However, this principle must be implemented with sophistication. This is where a robust harm reduction paradigm is not contradictory but complementary. Measures such as decriminalization of personal use coupled with increased investment in treatment, honest public education about neurological risks, and the promotion of non-chemical alternatives for anxiety management (e.g., ensuring access to nature, community centers, and therapy) represent a modern synthesis.
The goal is to create a cultural and policy environment that defaults to health promotion rather than damage control. This means strictly regulating the advertising, potency, and availability of all intoxicants—including alcohol and tobacco—with a clear public health rationale. It means framing sobriety and chemical-free coping not as a form of abstinence, but as a positive skill set for neurological and psychological flourishing.
Conclusion
The relationship between intoxicants and anxiety is one of cruel irony. What begins as a solution becomes the engine of the problem. The neurobiological evidence shows that intoxicants dysregulate the very systems they temporarily soothe. The psychological evidence reveals they arrest the development of crucial coping skills. The sociocultural evidence demonstrates that their widespread availability normalizes a pathogenic response to distress.
Therefore, a societal stance that prohibits intoxicants can be interpreted not as a puritanical restriction of freedom, but as a protective intervention aimed at preventing a widespread, debilitating form of suffering. It is a prohibition against the neglect of our own brain’s delicate balance, against the shortcut that leads to a dead end, and against the commercialization of despair. The ultimate aim is to foster a society that equips individuals with the internal resources and external support to face life’s inevitable anxieties with resilience, rather than offering them a chemical escape that deepens the trap. This requires moving beyond the polarized debate of total prohibition versus total laissez-faire, and towards a public health model that courageously prioritizes long-term mental well-being by creating environments where the healthiest choice—an intoxicant-free management of anxiety—is the easiest and most supported choice to make.
SOURCES
Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J., Hill, L., Holder, H., Homel, R., Livingston, M., Österberg, E., Rehm, J., Room, R., & Rossow, I. (2010). Alcohol: No ordinary commodity. Research and public policy (2nd ed.). Oxford University Press.
Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., Ware, M., Marmorstein, N., Cipriani, A., Dendukuri, N., & Mayo, N. (2019). Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis. JAMA Psychiatry, 76(4), 426–434.
Hall, W., & Lynskey, M. (2020). Assessing the public health impacts of legalizing recreational cannabis use: The US experience. World Psychiatry, 19(2), 179–186.
Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760–773.
Kushner, M. G., Abrams, K., & Borchardt, C. (2000). The relationship between anxiety disorders and alcohol use disorders: A review of major perspectives and findings. Clinical Psychology Review, 20(2), 149–171.
Spanagel, R., Noori, H. R., & Heilig, M. (2014). Stress and alcohol interactions: Animal studies and clinical significance. Trends in Neurosciences, 37(4), 219–227.
HISTORY
Current Version
Dec 30, 2025
Written By:
SUMMIYAH MAHMOOD